Plum Alley Investments is a venture capital firm based in New York, founded in 2012. The firm focuses on investing in early-stage, high-growth technology and healthcare companies that have at least one woman founder from the STEM fields. Plum Alley targets sectors such as smart hardware, intelligent machines, connected networks, agriculture technology, automation, safety, digital health, and longevity. By supporting advanced technologies and medical innovations, the firm aims to disrupt significant markets and create substantial value for society and the economy. As of April 2021, Plum Alley has invested over $35 million in 24 companies, fostering a diverse portfolio that emphasizes the importance of gender diversity in entrepreneurship.
COO, Plum Alley Ventures Company ; SVP Finance Plum Alley Ventures Company
Benjamin Robbins
Senior Associate Plum Alley Ventures Company
Liz Walsh
Managing Director, Plum Alley Ventures Company
Frances Walton
Partner
Alicia Zheng
Associate Plum Alley Ventures Company
41 past transactions
Openwater
Venture Round in 2024
Openwater is a San Francisco-based startup founded in 2016 that focuses on developing advanced medical technology aimed at diagnosing and treating diseases at the cellular level. The company has created a wearable device that leverages novel optoelectronic technology to offer high-resolution imaging capabilities, effectively replacing traditional MRI methods. By utilizing LCDs with small pixels, Openwater's device generates holographic images that minimize scattering and achieve MRI-like resolution. This innovation enables physicians to diagnose and treat diseases by targeting individual cells while preserving the surrounding tissue, thereby enhancing the precision and effectiveness of medical interventions.
Gameto
Series B in 2024
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.
Ketos
Private Equity Round in 2024
Ketos, Inc., operating as Ketos7 Inc, specializes in providing innovative hardware and software solutions for water management. Founded in 2015 and based in Milpitas, California, the company offers a comprehensive water intelligence platform that integrates industrial-grade hardware with an IoT communication framework and a powerful software platform. This technology enables real-time monitoring and analysis of various water quality parameters, including pH, dissolved solids, hardness, turbidity, and salinity. By delivering actionable insights, Ketos helps clients in agricultural, industrial, and municipal sectors manage water efficiency and ensure compliance with quality standards. The company aims to address critical global water management challenges through its advanced analytics technology and reliable service model.
Juvena Therapeutics
Series A in 2022
Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company specializes in developing protein-based therapeutics aimed at promoting tissue rejuvenation and addressing age-related diseases in the elderly. Its innovative platform focuses on discovering novel therapeutics that restore cellular functions, targeting conditions such as sarcopenia, wound healing, and neural regeneration. By decoding secreted proteins, Juvena Therapeutics aims to provide solutions for chronic and rare diseases, enhancing the quality of life for aging populations.
Gameto
Venture Round in 2022
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.
AiFi
Series B in 2022
AiFi Inc. is a technology company based in Santa Clara, California, that specializes in artificial intelligence solutions for retail. Founded in 2016, AiFi has developed a cashier-free software platform that utilizes sensor and camera networks to track shoppers as they navigate stores, fill their carts, and complete purchases seamlessly. This technology allows retailers to gather valuable data on inventory management and consumer shopping behaviors. The platform's flexibility enables it to adapt to various store formats without requiring additional shelf sensors, supporting different shopping experiences through app-based, credit card, or hybrid entry methods. AiFi has established partnerships with retailers worldwide, including major brands such as ALDI South Group, Carrefour, and Morrisons, and it operates the largest number of computer vision-powered autonomous stores globally. The company has secured $80 million in funding from notable investors, positioning it as a leader in the field of autonomous shopping solutions.
Gameto
Series A in 2022
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.
Helaina
Series A in 2021
Helaina is a biotechnology company focused on producing milk-equivalent baby formula that serves as an alternative to breast milk. By utilizing fermentation, Helaina generates bioactive proteins that closely mimic the functional proteins found in human milk, creating a new category of functional food products. These products are designed to provide nutritional options and immune benefits similar to those of breast milk, offering infants a viable alternative that incorporates the immune-nourishing properties of natural breast milk. Helaina's innovative approach aims to enhance infant nutrition and support healthy development.
Mammoth Biosciences
Series D in 2021
Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing innovative CRISPR solutions for a variety of applications. The company offers DETECTR™, a diagnostic platform that identifies specific nucleic acids in samples, aiding in the detection of diseases such as bacterial infections, cancer, and viral infections. Additionally, Mammoth Biosciences provides CRISPR-Cas systems for genome editing, targeting therapeutic areas including immuno-oncology, autoimmune diseases, and liver diseases. By harnessing proprietary ultracompact proteins and leveraging advanced research and development, Mammoth aims to create affordable point-of-care tests and enhance diagnostics across healthcare, agriculture, and environmental monitoring. Co-founded by CRISPR pioneer Jennifer Doudna, the company has attracted significant investment from institutional and individual backers.
Einride
Series B in 2021
Einride is a freight technology company founded in 2016, specializing in digital, electric, and autonomous shipping solutions. In 2019, it became the first company globally to operate an autonomous electric freight vehicle on public roads. Einride designs and manufactures advanced transportation vehicles that utilize all-electric technology, complemented by intelligent routing software. This software integrates customer and traffic data to optimize delivery times, battery life, and energy consumption. The company's technology allows for remote control of vehicles, providing users with a safe, emission-free, cost-effective, and sustainable freight mobility option. Additionally, Einride offers tools for users to manage electrification and automation, track shipments, oversee routes, and visualize data for enhanced operational insights.
Bitwise Industries
Series B in 2021
Bitwise Industries Inc. is a technology ecosystem company based in Fresno, California, focused on enhancing the local technology landscape. Established in 2013, the company operates Geekwise Academy, which provides accelerated coding education aimed at individuals of all ages, particularly from marginalized backgrounds. In addition to educational services, Bitwise Industries runs a custom software development firm, Shift3 Technologies, that connects experienced developers with entry-level programmers to create software solutions. The company also fosters community and collaboration by developing tech venues and co-working spaces that serve as hubs for technologists and technology companies. Through these initiatives, Bitwise Industries aims to empower individuals with vital tech skills and create pathways to meaningful careers in the technology sector.
Ashvattha Therapeutics
Series B in 2021
Ashvattha Therapeutics, Inc. is a biotechnology company focused on developing pharmaceutical products that address unmet medical needs in neurology, oncology, and ophthalmology, as well as inflammatory diseases. Founded in 2015 and headquartered in Redwood City, California, with research facilities in Baltimore, Maryland, the company specializes in hydroxyl dendrimer therapeutics. These innovative therapies are designed to selectively target actively endocytosing cells, such as reactive microglia and macrophages, which play significant roles in chronic inflammation and disease progression. By improving precision targeting, Ashvattha aims to minimize off-target toxicity, systemic side effects, and immunogenicity commonly associated with other therapeutic platforms. The company currently has a pipeline of nine therapeutics under development, focusing on enhancing treatment efficacy while reducing adverse effects for patients.
Air Protein
Series A in 2021
Air Protein, based in Berkeley, California, is a startup focused on creating sustainable protein from carbon dioxide. Utilizing a proprietary probiotic process, the company transforms CO2 into protein-enriched food products such as meat-free burgers, protein-enriched pasta, cereals, and beverages. This innovative approach allows for the production of protein without the use of hormones, pesticides, or herbicides, while also significantly reducing land and water usage compared to traditional meat production. Air Protein aims to provide a viable alternative for meat lovers seeking sustainable food options.
Aclima
Series B in 2020
Aclima Inc. is a climate-tech company based in San Francisco, California, with additional offices in Portland, Oregon, and New York City. Founded in 2007, Aclima specializes in the design and deployment of advanced environmental sensor networks that measure air pollution and greenhouse gases. The company’s technology provides high-resolution data, offering insights at block-by-block and source-level detail. Aclima Pro, their professional analytics software, translates vast amounts of scientific measurements into actionable intelligence for governments, businesses, and communities. By focusing on environmental health, Aclima aims to catalyze significant climate action, reduce emissions, and promote clean air for all. The company serves both commercial and government sectors and is backed by investors committed to climate innovation.
Ketos
Series B in 2020
Ketos, Inc., operating as Ketos7 Inc, specializes in providing innovative hardware and software solutions for water management. Founded in 2015 and based in Milpitas, California, the company offers a comprehensive water intelligence platform that integrates industrial-grade hardware with an IoT communication framework and a powerful software platform. This technology enables real-time monitoring and analysis of various water quality parameters, including pH, dissolved solids, hardness, turbidity, and salinity. By delivering actionable insights, Ketos helps clients in agricultural, industrial, and municipal sectors manage water efficiency and ensure compliance with quality standards. The company aims to address critical global water management challenges through its advanced analytics technology and reliable service model.
AiFi
Funding Round in 2020
AiFi Inc. is a technology company based in Santa Clara, California, that specializes in artificial intelligence solutions for retail. Founded in 2016, AiFi has developed a cashier-free software platform that utilizes sensor and camera networks to track shoppers as they navigate stores, fill their carts, and complete purchases seamlessly. This technology allows retailers to gather valuable data on inventory management and consumer shopping behaviors. The platform's flexibility enables it to adapt to various store formats without requiring additional shelf sensors, supporting different shopping experiences through app-based, credit card, or hybrid entry methods. AiFi has established partnerships with retailers worldwide, including major brands such as ALDI South Group, Carrefour, and Morrisons, and it operates the largest number of computer vision-powered autonomous stores globally. The company has secured $80 million in funding from notable investors, positioning it as a leader in the field of autonomous shopping solutions.
Ashvattha Therapeutics
Convertible Note in 2020
Ashvattha Therapeutics, Inc. is a biotechnology company focused on developing pharmaceutical products that address unmet medical needs in neurology, oncology, and ophthalmology, as well as inflammatory diseases. Founded in 2015 and headquartered in Redwood City, California, with research facilities in Baltimore, Maryland, the company specializes in hydroxyl dendrimer therapeutics. These innovative therapies are designed to selectively target actively endocytosing cells, such as reactive microglia and macrophages, which play significant roles in chronic inflammation and disease progression. By improving precision targeting, Ashvattha aims to minimize off-target toxicity, systemic side effects, and immunogenicity commonly associated with other therapeutic platforms. The company currently has a pipeline of nine therapeutics under development, focusing on enhancing treatment efficacy while reducing adverse effects for patients.
Diligent Robotics
Series A in 2020
Diligent Robotics Inc. is a company based in Austin, Texas, that develops and manufactures hospital service robots, specifically designed to assist clinical and nursing staff with logistical tasks. Its flagship product, Moxi, is a robotic assistant equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities. Moxi works collaboratively with healthcare teams, allowing clinical staff to focus more on direct patient care, thereby enhancing patient satisfaction and improving the overall quality and safety of service. Founded in 2017, Diligent Robotics aims to integrate artificial intelligence technologies into everyday environments, supporting healthcare providers in dynamic and semi-structured settings.
Mammoth Biosciences
Series B in 2020
Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing innovative CRISPR solutions for a variety of applications. The company offers DETECTR™, a diagnostic platform that identifies specific nucleic acids in samples, aiding in the detection of diseases such as bacterial infections, cancer, and viral infections. Additionally, Mammoth Biosciences provides CRISPR-Cas systems for genome editing, targeting therapeutic areas including immuno-oncology, autoimmune diseases, and liver diseases. By harnessing proprietary ultracompact proteins and leveraging advanced research and development, Mammoth aims to create affordable point-of-care tests and enhance diagnostics across healthcare, agriculture, and environmental monitoring. Co-founded by CRISPR pioneer Jennifer Doudna, the company has attracted significant investment from institutional and individual backers.
Einride
Series A in 2019
Einride is a freight technology company founded in 2016, specializing in digital, electric, and autonomous shipping solutions. In 2019, it became the first company globally to operate an autonomous electric freight vehicle on public roads. Einride designs and manufactures advanced transportation vehicles that utilize all-electric technology, complemented by intelligent routing software. This software integrates customer and traffic data to optimize delivery times, battery life, and energy consumption. The company's technology allows for remote control of vehicles, providing users with a safe, emission-free, cost-effective, and sustainable freight mobility option. Additionally, Einride offers tools for users to manage electrification and automation, track shipments, oversee routes, and visualize data for enhanced operational insights.
Evrnu
Series A in 2019
Evrnu is a textile innovations company focused on developing regenerative fiber technologies that convert discarded clothing into high-quality fibers. By breaking down cotton garment waste to the molecular level, Evrnu creates engineered fibers with enhanced environmental benefits. This process supports a circular ecosystem by enabling garment manufacturers to produce fibers such as regenerative cellulosic, regenerative polyester, and recoverable stretch. The company's approach not only addresses textile waste but also promotes sustainable practices within the fashion industry.
Node
Venture Round in 2019
Node, recently acquired by SugarCRM, fuels Sugar's time-aware CX platform to help businesses by automatically forecasting expected outcomes and highlighting previously unforeseen challenges and opportunities. Extending Sugar’s time-aware CX platform, Node’s AI technology adds the most coveted element of time—the future. The combined solution offers wide-ranging capabilities for sales, marketing, and service teams. Node enables users of business applications to see into the future. Powered by Artificial Intuition™ technology, Node is the first turnkey AI-as-a-service platform focused on powering predictable business outcomes, which enterprises can use to quickly and seamlessly build advanced AI into both customer-facing and internal applications without investing years and millions of dollars on risky AI experiments. Applications powered by Node can deliver predictions that enable users to make smarter connections and decisions about how to engage with customers, employees, investors, and partners. Node was founded by Google's youngest employee, Falon Fatemi, and it's renowned technology team includes the Godfather of Search, Louis Monier who created Alta Vista, and Michael Radovancevich former CTO of Taleo and OpenX. Node is backed by Mark Cuban, NEA, Avalon Ventures, and JetBlue Technology Ventures.
BioEclipse Therapeutics
Series A in 2019
BioEclipse Therapeutics is a clinical-stage biopharmaceutical company based in San Francisco, California, focused on developing curative immuno-oncology therapeutics for cancer patients. The company’s flagship product, CRX-100, represents a novel combination therapy that enhances the immune system's ability to combat cancer without the need to reengineer patients' cells. By utilizing a proprietary approach that combines activated immune cells with an adapted oncolytic virus, BioEclipse Therapeutics aims to selectively target and destroy malignant cells while improving tumor visibility to the immune system. The company's mission is to advance clinical outcomes and enhance the quality of life for cancer patients, with the ultimate goal of transforming cancer into a curable disease. BioEclipse Therapeutics was established in 2006 and was previously known as ConcentRx Inc before rebranding in 2017.
Bitwise Industries
Series A in 2019
Bitwise Industries Inc. is a technology ecosystem company based in Fresno, California, focused on enhancing the local technology landscape. Established in 2013, the company operates Geekwise Academy, which provides accelerated coding education aimed at individuals of all ages, particularly from marginalized backgrounds. In addition to educational services, Bitwise Industries runs a custom software development firm, Shift3 Technologies, that connects experienced developers with entry-level programmers to create software solutions. The company also fosters community and collaboration by developing tech venues and co-working spaces that serve as hubs for technologists and technology companies. Through these initiatives, Bitwise Industries aims to empower individuals with vital tech skills and create pathways to meaningful careers in the technology sector.
One Concern
Series B in 2019
One Concern, Inc. is a climate resilience technology company that develops an artificial intelligence-based platform to assist governments and organizations in preparing for and responding to natural disasters. Founded in 2015 and headquartered in Menlo Park, California, with an additional office in Tokyo, Japan, One Concern utilizes machine learning, hazard modeling, and predictive analytics to create post-disaster damage maps and provide daily situational reports. Its flagship tool, Seismic Concern, focuses on earthquake preparedness and response, while the platform also addresses various disasters like hurricanes, floods, and wildfires, as well as chronic stresses such as poverty and climate change. By delivering capabilities throughout the lifecycle of disaster preparedness, mitigation, response, and recovery, One Concern aims to make disasters less devastating and enhance overall community resilience. Recognized as a 2019 Technology Pioneer, the company is part of the World Economic Forum’s Global Innovators community.
Markable Creators
Series A in 2019
Markable Creators specializes in transforming social media content into shoppable experiences through advanced image recognition and AI-driven technology. By utilizing computer vision and deep learning, the platform allows users to identify fashion products featured in videos and photos, seamlessly linking them to e-commerce sites for easy purchasing. With a vast inventory of 200 million SKUs, which are regularly updated to ensure availability, Markable Creators addresses the growing demand for social commerce, especially among Gen Z consumers who increasingly discover products through digital content rather than traditional retail channels. The company has established partnerships with major social media platforms in Asia and has been recognized for its innovative solutions, winning top accolades for its contributions to AI and e-commerce integration.
Ketos
Series A in 2019
Ketos, Inc., operating as Ketos7 Inc, specializes in providing innovative hardware and software solutions for water management. Founded in 2015 and based in Milpitas, California, the company offers a comprehensive water intelligence platform that integrates industrial-grade hardware with an IoT communication framework and a powerful software platform. This technology enables real-time monitoring and analysis of various water quality parameters, including pH, dissolved solids, hardness, turbidity, and salinity. By delivering actionable insights, Ketos helps clients in agricultural, industrial, and municipal sectors manage water efficiency and ensure compliance with quality standards. The company aims to address critical global water management challenges through its advanced analytics technology and reliable service model.
Mammoth Biosciences
Series A in 2018
Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing innovative CRISPR solutions for a variety of applications. The company offers DETECTR™, a diagnostic platform that identifies specific nucleic acids in samples, aiding in the detection of diseases such as bacterial infections, cancer, and viral infections. Additionally, Mammoth Biosciences provides CRISPR-Cas systems for genome editing, targeting therapeutic areas including immuno-oncology, autoimmune diseases, and liver diseases. By harnessing proprietary ultracompact proteins and leveraging advanced research and development, Mammoth aims to create affordable point-of-care tests and enhance diagnostics across healthcare, agriculture, and environmental monitoring. Co-founded by CRISPR pioneer Jennifer Doudna, the company has attracted significant investment from institutional and individual backers.
Aclima
Series A in 2018
Aclima Inc. is a climate-tech company based in San Francisco, California, with additional offices in Portland, Oregon, and New York City. Founded in 2007, Aclima specializes in the design and deployment of advanced environmental sensor networks that measure air pollution and greenhouse gases. The company’s technology provides high-resolution data, offering insights at block-by-block and source-level detail. Aclima Pro, their professional analytics software, translates vast amounts of scientific measurements into actionable intelligence for governments, businesses, and communities. By focusing on environmental health, Aclima aims to catalyze significant climate action, reduce emissions, and promote clean air for all. The company serves both commercial and government sectors and is backed by investors committed to climate innovation.
Shine
Series A in 2018
Shine is a developer of a self-care communication application designed to make well-being accessible. Their application is a messaging bot that gives out life advice and positive reinforcements including actionable tips based on confidence, daily happiness, mental health, productivity, and self-care audio challenges to grow on the go through sms texts on a daily basis, enabling people with anxiety and depression to get career and life advice to take proper care of themselves.
BioEclipse Therapeutics
Seed Round in 2018
BioEclipse Therapeutics is a clinical-stage biopharmaceutical company based in San Francisco, California, focused on developing curative immuno-oncology therapeutics for cancer patients. The company’s flagship product, CRX-100, represents a novel combination therapy that enhances the immune system's ability to combat cancer without the need to reengineer patients' cells. By utilizing a proprietary approach that combines activated immune cells with an adapted oncolytic virus, BioEclipse Therapeutics aims to selectively target and destroy malignant cells while improving tumor visibility to the immune system. The company's mission is to advance clinical outcomes and enhance the quality of life for cancer patients, with the ultimate goal of transforming cancer into a curable disease. BioEclipse Therapeutics was established in 2006 and was previously known as ConcentRx Inc before rebranding in 2017.
Vyv
Venture Round in 2018
Vyv, formerly known as Vital Vio, Inc., specializes in the design and manufacture of antimicrobial lighting systems under the VioSafe brand. The company produces a range of products, including under cabinet lights, T8 replacement bulbs, and various types of LED luminaires, all engineered to combat infectious pathogens. These innovative lighting solutions are employed in diverse commercial environments such as hospitals, laboratories, food storage facilities, gyms, and schools, among others. Vyv's technology leverages visible light to disrupt the cell membranes of harmful bacteria and viruses, providing a continuous method for infection control. Established in 2012 and based in Troy, New York, the company serves a broad clientele, including notable institutions like Duke University and UCLA Health, and also explores licensing opportunities for consumer and residential applications.
Vow To Be Chic
Venture Round in 2017
Vow To Be Chic is an online platform that specializes in the rental of designer bridesmaid dresses and Little White Dresses. By providing an alternative to the traditional model of purchasing dresses, Vow To Be Chic addresses the financial burden and logistical challenges often faced by bridesmaids, whose average costs can reach $1,700. The service facilitates a seamless experience by offering features such as at-home try-ons, shipping, dry cleaning, and insurance, allowing users to rent or buy dresses conveniently. This model not only saves money but also alleviates the stress of coordinating dress selection and fittings for multiple bridesmaids, regardless of their locations.
ThinkCERCA
Series B in 2017
ThinkCERCA operates a personalized literacy platform that focuses on enhancing students' reading, writing, and critical thinking skills through the practice of argumentative writing. The platform supports educators in facilitating collaborative discussions and debates, enabling them to design and assess lessons centered on argumentation. By tracking real-time progress, ThinkCERCA allows teachers to effectively monitor student development. The platform is utilized by educators and students across all 50 states and in 130 countries. ThinkCERCA has gained recognition in the education sector, having partnered with notable organizations and received accolades for its innovative approach to literacy and critical thinking education. The company has also been acknowledged by various educational publications and received grants supporting its mission to improve literacy outcomes.
Tinkergarten
Series A in 2017
Tinkergarten, Inc. is dedicated to providing outdoor play-based learning classes and activities for children aged 18 months to 8 years. Founded in 2014 and headquartered in Northampton, Massachusetts, the company connects families with local leaders who facilitate activity-based classes designed to foster essential developmental skills in a natural setting. Tinkergarten's approach emphasizes the importance of early childhood education in outdoor environments, allowing children to learn through play while enabling parents to engage actively in their children's learning journeys. By creating a network of community leaders, Tinkergarten aims to elevate the quality of early education and support parents in raising healthy, confident, and capable children.
Markable Creators
Venture Round in 2017
Markable Creators specializes in transforming social media content into shoppable experiences through advanced image recognition and AI-driven technology. By utilizing computer vision and deep learning, the platform allows users to identify fashion products featured in videos and photos, seamlessly linking them to e-commerce sites for easy purchasing. With a vast inventory of 200 million SKUs, which are regularly updated to ensure availability, Markable Creators addresses the growing demand for social commerce, especially among Gen Z consumers who increasingly discover products through digital content rather than traditional retail channels. The company has established partnerships with major social media platforms in Asia and has been recognized for its innovative solutions, winning top accolades for its contributions to AI and e-commerce integration.
Cordex Systems
Series A in 2017
Cordex Systems designs and manufactures a cardiovascular diagnostic device. Its product includes the Cordex EnDys System is a diagnostic tool that provides both early detection and ongoing monitoring of cardiovascular disease by measuring endothelial dysfunction.
EpiBone
Convertible Note in 2016
EpiBone, Inc. is a biotechnology company based in Brooklyn, New York, focused on developing advanced solutions for bone and cartilage repair. Founded in 2013, EpiBone utilizes patient-specific scans and their own stem cells to create customized bone grafts, which are cultivated in a bioreactor to facilitate growth. The company aims to improve skeletal repair and enhance bone formation and regeneration through its innovative technologies. EpiBone's lead product, a living 3D bone graft, successfully completed its Phase I/IIa clinical trial in August 2023. Additionally, the company is advancing its cartilage repair pipeline, which includes an allogeneic osteochondral plug that received Investigational New Drug approval in July 2023, and an injectable cartilage filler, partly funded by the Department of Defense. Through these developments, EpiBone seeks to revolutionize orthopedic repair and provide patients with more effective treatment options.
Tinkergarten
Seed Round in 2016
Tinkergarten, Inc. is dedicated to providing outdoor play-based learning classes and activities for children aged 18 months to 8 years. Founded in 2014 and headquartered in Northampton, Massachusetts, the company connects families with local leaders who facilitate activity-based classes designed to foster essential developmental skills in a natural setting. Tinkergarten's approach emphasizes the importance of early childhood education in outdoor environments, allowing children to learn through play while enabling parents to engage actively in their children's learning journeys. By creating a network of community leaders, Tinkergarten aims to elevate the quality of early education and support parents in raising healthy, confident, and capable children.
Talent Sonar
Series A in 2016
Talent Sonar, following its merger with TalVista, focuses on assisting companies in managing unconscious bias to enhance diversity hiring practices. Through services such as redacted resume review, job description optimization, and structured interviews, Talent Sonar aims to help organizations create more inclusive and equitable recruitment processes. By leveraging technology and data-driven approaches, Talent Sonar aims to support companies in building diverse and talented teams.
Trustify
Seed Round in 2015
Trustify, Inc. operates an on-demand technology platform that connects individuals and businesses with licensed private investigators across the United States. Founded in 2015 and based in Arlington, Virginia, the company provides a range of services including real-time observation, digital monitoring, background checks, and social media analysis. Trustify's platform facilitates various investigative needs such as locating witnesses, serving legal papers, asset recovery, and evidence collection for legal cases. Additionally, it supports the insurance industry by offering services related to workman's compensation, liability investigations, and surveillance. Trustify aims to make truth, trust, and safety accessible to everyone through its network of professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.